The main strengths of this study are the acute clinical setting
and highly clinically relevant representation of consecutively
recruited participants, making the results more generalisable to
everyday clinical circumstances. Other strengths are the high
quality of the consecutive data-collection and available information
on the large majority of known risk-factors for suicide in
schizophrenia. We had access to more comprehensive clinical data
than for instance registry-based studies, which have provided a
substantial amount of the established evidence-base.